C WorldWide Group Holding A/S - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 159 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2018. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
C WorldWide Group Holding A/S ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q1 2019$2,647,000
+179.8%
38,168
+75.4%
0.03%
+142.9%
Q4 2018$946,000
-72.1%
21,765
-50.9%
0.01%
-67.4%
Q3 2018$3,386,000
-16.6%
44,350
-16.1%
0.04%
-23.2%
Q2 2018$4,061,000
+28.5%
52,834
-14.8%
0.06%
+14.3%
Q1 2018$3,160,000
-4.6%
61,977
-13.2%
0.05%
+2.1%
Q4 2017$3,313,000
-19.9%
71,440
-8.0%
0.05%
-18.6%
Q3 2017$4,138,000
-13.4%
77,691
+1.0%
0.06%
-19.2%
Q2 2017$4,778,000
+20.1%
76,927
+31.1%
0.07%
+9.0%
Q1 2017$3,977,000
+4.3%
58,670
+8.2%
0.07%
-9.5%
Q4 2016$3,813,000
-28.8%
54,225
-28.2%
0.07%
-21.3%
Q3 2016$5,356,000
+79.5%
75,500
+23.8%
0.09%
+64.9%
Q2 2016$2,984,000
+17.9%
61,000
+52.5%
0.06%
+16.3%
Q1 2016$2,532,000
-43.6%
40,0000.0%0.05%
-38.0%
Q4 2015$4,487,000
+16.5%
40,0000.0%0.08%
+21.5%
Q3 2015$3,852,00040,0000.06%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2018
NameSharesValueWeighting ↓
First Light Asset Management, LLC 437,512$31,772,0002.80%
RTW INVESTMENTS, LP 1,373,284$99,728,0002.06%
Rock Springs Capital Management LP 1,028,109$74,661,0001.88%
Privium Fund Management B.V. 112,727$8,186,0001.81%
Avidity Partners Management LP 869,000$63,107,0001.31%
SUVRETTA CAPITAL MANAGEMENT, LLC 525,100$38,133,0001.16%
Boxer Capital, LLC 200,000$14,524,0000.75%
SECTOR GAMMA AS 46,221$3,357,0000.73%
FEDERATED HERMES, INC. 3,987,728$289,589,0000.65%
EMERALD ADVISERS, LLC 223,952$16,263,0000.62%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders